| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/01/1995 | EP0640128A1 Attenuated respiratory syncytial virus vaccine compositions |
| 02/23/1995 | WO1995005460A2 Feline immunodeficiency virus isolate ncsu 1 |
| 02/23/1995 | WO1995005454A1 Engineered bacteriophages and vaccines containing them |
| 02/23/1995 | WO1995005201A1 Adenoviruses having modified fiber proteins |
| 02/23/1995 | WO1995005194A1 Vaccine compositions |
| 02/22/1995 | EP0639640A1 Poultry vaccine containing infections bronchitis virus serotype 4/91 |
| 02/22/1995 | EP0319570B1 Recombinant human cytomegalovirus containing foreign gene and use thereof |
| 02/21/1995 | US5391491 Avian embryo cell aggregate biomass for producing tick-born encephalitis virus/virus antigen |
| 02/16/1995 | WO1995004546A1 Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses |
| 02/16/1995 | WO1995004545A1 Inactivated respiratory syncytial viral vaccines |
| 02/16/1995 | WO1994029472A3 Mengovirus as a vector for expression of foreign polypeptides |
| 02/16/1995 | CA2168566A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 02/15/1995 | EP0638316A1 Recombinant adenovirus vaccines |
| 02/15/1995 | EP0638126A1 Inhibitory factor |
| 02/15/1995 | EP0638124A1 Oral infection of insect larvae with pre-occluded baculovirus particles |
| 02/15/1995 | EP0638122A1 Cdna sequence of dengue virus serotype 1 (singapore strain) |
| 02/15/1995 | EP0587780B1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 02/12/1995 | CA2130202A1 Recombinant adenovirus vaccines |
| 02/09/1995 | WO1995004139A1 Modified dna virus vectors and uses therefor |
| 02/09/1995 | CA2167706A1 Modified dna virus vectors and uses therefor |
| 02/08/1995 | EP0637631A2 Highly efficient expression of a polypeptide containing a modified preS1 region of the major hepatitis B virus antigen |
| 02/08/1995 | EP0637250A1 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 02/07/1995 | US5387519 Recombinant avipoxvirus |
| 02/02/1995 | WO1995003414A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 02/02/1995 | WO1995003407A2 Oligonucleotides with activity against human immunodeficiency virus |
| 02/02/1995 | WO1995003070A1 Recombinant swinepox virus |
| 02/02/1995 | WO1994029446A3 Intracellular binding proteins and use thereof |
| 02/01/1995 | EP0636172A1 Genetically engineered attenuated viruses |
| 01/31/1995 | CA2129156A1 High level expression of polypeptide that contains modified pres1 region of hepatitis b virus large antigen |
| 01/26/1995 | WO1995002697A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/26/1995 | WO1995002688A1 Methods and compositions for the removal of viruses and uses thereof |
| 01/26/1995 | WO1995002417A1 Methods for the cultivation of infectious laryngotracheitis virus and egg drop syndrome virus |
| 01/26/1995 | WO1995002324A1 Method of inactivation of viral and bacterial blood contaminants |
| 01/26/1995 | CA2167392A1 Methods and compositions for the removal of viruses and uses thereof |
| 01/26/1995 | CA2144040A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/24/1995 | US5384122 Herpesvirus particles and vaccine |
| 01/18/1995 | EP0633942A1 Non-infectious hiv particles and uses therefor |
| 01/17/1995 | US5382509 Method and kit for the diagnosis of human papillomavirus type 41 |
| 01/17/1995 | US5382425 Recombinant swinepox virus |
| 01/12/1995 | WO1995001457A1 Htlv-iinra compositions and assays for detecting htlv infection |
| 01/12/1995 | WO1995001438A1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
| 01/12/1995 | WO1995001429A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 01/12/1995 | CA2163979A1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
| 01/10/1995 | US5380830 Molecular clones of bovine immunodeficiency-like virus |
| 01/05/1995 | WO1995000655A1 Adenovirus vectors for gene therapy |
| 01/05/1995 | WO1995000648A1 Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection |
| 01/05/1995 | WO1995000631A1 System for viral inactivation of blood |
| 01/05/1995 | WO1994021792A3 Inhibition of selected tumor growth with recombinant viral vectors |
| 01/05/1995 | DE4405841C1 Multipotent non-specific immunity inducers based on combinations of poxvirus components, processes for their preparation and their use as pharmaceuticals |
| 01/05/1995 | CA2166104A1 Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection |
| 01/05/1995 | CA2165065A1 System for viral inactivation of blood |
| 01/04/1995 | EP0631633A1 Reaction-based selection for expression of and concentration of catalytic moieties |
| 01/04/1995 | EP0631624A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 01/03/1995 | US5378811 Pure C3b inactivator and a process for producing said protein |
| 01/03/1995 | US5378467 Cell-free Marek's disease virus vaccine |
| 01/03/1995 | US5378457 Immunology, genetic engineering |
| 12/28/1994 | EP0630409A1 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 12/22/1994 | WO1994029472A2 Mengovirus as a vector for expression of foreign polypeptides |
| 12/22/1994 | WO1994029446A2 Intracellular binding proteins and use thereof |
| 12/22/1994 | WO1994029440A1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors |
| 12/22/1994 | WO1994029439A1 High yielding influenza viruses |
| 12/22/1994 | WO1994029438A1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 12/22/1994 | WO1994028930A1 Malaria recombinant poxvirus vaccine |
| 12/22/1994 | CA2168124A1 Malaria recombinant poxvirus vaccine |
| 12/22/1994 | CA2164946A1 High yielding influenza viruses |
| 12/22/1994 | CA2164297A1 Mengovirus as a vector for expression of foreign polypeptides |
| 12/21/1994 | EP0629239A1 INSECTICIDAL TOXINS FROM THE PARASITIC WASP $i(BRACON HEBETOR) |
| 12/21/1994 | EP0629135A1 Viral inactivation method |
| 12/21/1994 | EP0629131A1 ANTIGENS PROTECTIVE AGAINST $i(ECHINOCOCCUS GRANULOSUS) INFECTION AND VACCINES CONTAINING SUCH ANTIGENS |
| 12/20/1994 | US5374558 Recombinant DNA comprising promoter sequence in fowlpox virus genome transcribably linked to foreign gene |
| 12/20/1994 | US5374519 Oligopeptides comprising p18 protein of human immunodeficiency virus (HIV), compositions comprising peptides of p18 protein of HIV, and diagnostic kits and methods for detecting acquired immune deficiency syndrome (AIDS) |
| 12/20/1994 | US5374424 Multivalent felv-infected feline vaccine |
| 12/20/1994 | CA1333562C Preservation of viruses |
| 12/14/1994 | EP0627936A1 Feline infectious peritonitis vaccine and method of preparation |
| 12/14/1994 | EP0382840B1 Aloe compositions and uses thereof |
| 12/14/1994 | CN1096223A Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases |
| 12/08/1994 | WO1994028152A1 Defective adenoviruses and corresponding complementation lines |
| 12/08/1994 | WO1994028145A2 Expression of urokinase plasminogen activator inhibitors |
| 12/08/1994 | WO1994028120A1 Process for the sterilization of biological compositions and the product produced thereby |
| 12/08/1994 | WO1994028115A1 Direct and biochemically functional detection process of retrovirus in biological samples |
| 12/08/1994 | WO1994028114A1 GENE INSERTION BY DIRECT LIGATION $i(IN VITRO) |
| 12/08/1994 | WO1994027590A1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 12/08/1994 | WO1994021807A3 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
| 12/08/1994 | CA2168686A1 Process for growing a virus |
| 12/08/1994 | CA2162855A1 Expression of urokinase plasminogen activator inhibitors |
| 12/08/1994 | CA2141206A1 Gene insertion by direct ligation in vitro |
| 12/07/1994 | EP0627488A1 Method for producing filamentous phages displaying on the surface of the capsid peptides capable of binding biotin, and filamentous phages and peptides thus obtained |
| 12/06/1994 | US5371206 DNA encoding chimeric fibroblast growth factors |
| 12/06/1994 | US5370869 Infusion into patient platelet concentrate that has been in contact with povidone-iodine or povidone-hydrogen peroxide or mixture to inactivate or destroy pathogenic microorganism |
| 11/30/1994 | EP0626008A1 Vaccine containing acemannan as an adjuvant |
| 11/30/1994 | EP0509008B1 Biomass for the production of viruses/virus antigens |
| 11/29/1994 | US5369025 Recombinant fowlpox vaccine for protection against Marek's disease |
| 11/24/1994 | WO1994026914A1 Adenoviral vectors of animal origin and use thereof in gene therapy |
| 11/24/1994 | WO1994026904A1 Hepatitis b virus mutants, reagents and methods for detection |
| 11/24/1994 | WO1994026894A1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE |
| 11/24/1994 | WO1994026886A2 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 11/24/1994 | WO1994026776A1 Therapeutic compounds |
| 11/24/1994 | WO1994026304A1 Otitis media vaccine |
| 11/24/1994 | CA2162928A1 Von hippel-lindau (vhl) disease gene and corresponding cdna and methods for detecting carriers of the vhl disease gene |
| 11/23/1994 | EP0625204A1 Hepatitis therapeutics |